Latest pancreatic cancer News

Survivor Joins Cancer Campaign
Weight-loss jabs linked to lower cancer risk compared with insulin – new study
Amplia anounces completion of recruitment of first 26 patients in Phase 2 trial
PhD Top Up Scholarship supports research into pancreatic cancer
Risky Drinking Even Riskier For Women
Fifth patient is treated with the OncoSil device in PANCOSIL trial
EnGeneIC and Singapore Institute of Advanced Medicine Holdings Forge Strategic Partnership to Revolutionise Cancer Treatment in Asia
Margaret’s How Mother’s Struggle Transformed Lives
Pancreatic cancer research receives $8m philanthropic funding boost
Cancer is increasingly survivable – but it shouldn’t depend on your ability to ‘wrangle’ the health system
Binge drinking is a growing public health crisis − a neurobiologist explains how research on alcohol use disorder has shifted
Wish Granted Just In Time For Proud Nan
‘My Mum Was Everything To Me’
Cancer: here’s the role exercise plays, from prevention to treatment
Robin is hosting a morning tea in honour of three of her closest family members who she has lost to cancer
Personalised mRNA vaccines: a revolutionary new approach in melanoma treatment
Tour de Cure backs further development of Noxopharm’s preclinical brain cancer candidate
First Turkish patient treated with OncoSil cancer treatment device
Cancer Research KI network support translational collaboration in molecular mechanisms at Schulte lab
Tour de Cure grant for brain cancer research
Cancer often requires more than one treatment − an oncologist explains why some patients like Kate Middleton receive both chemotherapy and surgery
She is awarded the Sjöberg Prize for laying the foundations of a cancer vaccine
Can4Cancer pedals towards $20 million raised for cancer research
Pancreatic Cancer Rising In Younger People
New data shows top five cancers projected to affect people in Nepean Blue Mountains Local Health District
Raising our voices for better palliative care
UNSW researchers receive more than $20m in Ideas and Development Grants
FDA grants fast-track designation for EnGeneIC’s pancreatic cancer candidate
EnGeneIC granted FDA “Fast-Track” Designation for Novel Armed Nanocell Drug Conjugate (ANDC) Pancreatic Cancer Therapeutic
OncoSil Medical onboards first patient in the PANCOSIL clinical trial
Korean regulator approves Amplia Therapeutics’ pancreatic cancer trial
Dr Ben Wylie research to develop kinder and less toxic treatments for cancer
EnGeneIC’s breakthrough Armed Nanocell Drug Conjugate (ANDC) treatment shows promising results in Pancreatic cancer patients who have run out of treatment options
November is Pancreatic Cancer Awareness Month
$5 million NHMRC funding for cancer research
Mater Researcher shares in $1.8 million to fight one of Australia’s deadliest cancers
National register to help fight pancreatic cancer
Landmark blood test to detect silent, lethal cancer
Walk4Rita helps in pancreatic cancer fight
Imfinzi plus chemotherapy approved in China as first immunotherapy regimen for patients with locally advanced or metastatic biliary tract cancer
From warzone doctor to Geelong surgeon
November is Pancreatic Cancer Awareness Month
Imugene says next cohort reached in intravenous arms of monotherapy and combination study
Raising Pancreatic Cancer Awareness in November
Enhertu demonstrated clinically meaningful survival across multiple HER2-expressing advanced solid tumours in DESTINY-PanTumor02 Phase II trial
Important workers compensation reforms supporting fire-fighters pass Parliament
Arovella Therapeutics licences monoclonal antibody for cell therapy development
US FDA grants Orphan Drug Designation for Noxopharm’s CRO-67